RecallRadar

FDA Drug recall D-0310-2025

Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (…

On 2025-04-16 the FDA classified a Class II recall of Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (… by Zydus Pharmaceuticals Usa, citing presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0310-2025
ClassificationClass II
Statuscompleted
Initiated2025-03-21
Published2025-04-16
Last updated2026-09-13 11:52 UTC
CompanyZydus Pharmaceuticals Usa
DistributionUS

Product

Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.

Reason

Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.

Identifiers

ndc68382-018-06
ndc68382-018-14
ndc68382-018-16
ndc68382-018-01
ndc68382-018-05
ndc68382-018-10
ndc68382-019-06
ndc68382-019-14
ndc68382-019-16
ndc68382-019-01
ndc68382-019-05
ndc68382-019-10
ndc68382-020-06
ndc68382-020-14
ndc68382-020-16
ndc68382-020-01
ndc68382-020-05
ndc68382-020-10
ndc68382-021-06
ndc68382-021-14
ndc68382-021-16
ndc68382-021-01
ndc68382-021-05
ndc68382-021-10
ndc68382-101-06
ndc68382-101-14
ndc68382-101-16
ndc68382-101-01
ndc68382-101-05
ndc68382-101-10
code_infoLot #: M314265, Exp.: 31 October 2025.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0310-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.